01 / DESIGN
What was studied?
A carrier peptide was combined with insulin or a parathyroid-hormone fragment under different conditions in cell and animal models.
02 / FINDINGS
What did the researchers report?
Transport changes tracked carrier stability more closely than the amount of peptide-cargo complex formation in the tested systems.
03 / LIMITS
How should it be interpreted?
More complex formation does not necessarily mean better delivery. The findings are formulation-specific and do not establish oral effectiveness or interchangeability of catalog peptides.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.